EduardoHumbertoTschenMD

Dermatology • Albuquerque, NM

Physician

Join to view full profile

Dr. Tschen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tschen's full profile

Already have an account?

Office
1203 Coal Ave Se
Albuquerque, NM 87106
Phone+1 505-247-4220

Fax+1 505-247-0367

Education & Training

University of Texas Medical Branch HospitalsResidency, Dermatology, 1979 - 1980
University of New Mexico School of MedicineResidency, Dermatology, 1977 - 1978
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 1976 - 1977
Universidad de San Carlos FOMSClass of 1974

Certifications & Licensure

NM State Medical License 1983 - 2026
TX State Medical License 1980 - 2024
PA State Medical License 1977 - 2002
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) Start of enrollment: 2007 Jul 01
Completed
Phase 1
TDT 067 Onychomycosis Study Start of enrollment: 2010 Apr 01
Unknown status
Phase 3
Safety Study of Cosmetic Tissue Augmentation in People of Color Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Dose Response Study of Patients With Erythematous Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
TDT 067 Open Label Multi-Dose Onychomycosis Study Start of enrollment: 2009 Dec 01
Completed
Phase 2
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

52 citations
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind C...
Angela Yen Moore, Lawrence Green, Suzanne Bruce, Neil S. Sadick, Eduardo Tschen
Journal of Drugs in Dermatology. 2018-09-01
90 citations
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha, Joseph F. Fowler, Adelaide A. Hebert
Journal of the American Academy of Dermatology. 2017-10-01
5 citations
Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle...
David M. Pariser, Michael Bukhalo, Scott Guenthner, Steven Kempers, Stephen Shideler
Journal of Drugs in Dermatology. 2017-03-01

Professional Memberships

American Academy of Dermatology - AAD
Fellow